Gensight Biologics

GenSight’s Eye Disease Gene Therapy Shows Sustained Vision Improvement
BioSpace
Wed, 05/15/19 - 11:35 pm
Gensight Biologics
clinical trials
gene therapy
LHON
Gensight scouts a $100M IPO for its ocular gene therapies
Fierce Biotech
Wed, 07/8/15 - 11:35 am
Gensight Biologics
IPOs
ocular gene therapies
gene therapy
Gene Therapy's Big Comeback
Forbes
Wed, 03/26/14 - 08:07 am
gene therapy
Bristol-Myers Squibb
Bluebird Bio
NightstaRx
Voyager Therapeutics
uniQure
Celladon
Juno Therapeutics
Editas Medicine
Gensight Biologics
Audentes Therapeutics
Dimension Therapeutics